Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Barinthus Biotherapeutics ( (BRNS) ) has issued an announcement.
Barinthus Biotherapeutics plc has announced the promotion of Graham Griffiths from Chief Business Officer to Chief Operating Officer, effective September 1, 2024. Griffiths, who joined the company in 2017 and has a rich background in biotech leadership, will see his salary increase to £336,144 with this new role. The promotion is based solely on merit, with no family or insider connections influencing the decision.
For detailed information about BRNS stock, go to TipRanks’ Stock Analysis page.
